Journal Mobile Options
Table of Contents
Vol. 75, No. 4, 2000
Issue release date: March 2002
Stereotact Funct Neurosurg 2000;75:167–175
(DOI:10.1159/000048402)

Continuous Intrathecal Clonidine Administration for the Treatment of Neuropathic Pain

Uhle E.-I. · Becker R. · Gatscher S. · Bertalanffy H.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

In many cases, the treatment of neuropathic pain by intrathecal opioids fails to meet expectations. In a trial involving 10 patients, the intrathecal administration of clonidine combined with opioids in the treatment of chronic pain was introduced in our department for the first time. Eight patients with neuropathic pain syndromes were subjected to a continuous intrathecal clonidine application in addition to intrathecal morphine. At an average dose of 44 µg clonidine/day, a 70–100% reduction in pain was achieved. Residual non-neuropathic pain in 4 of 8 patients was successfully treated with clonidine and low doses of opioids. On the basis of the results achieved so far, we recommend that clonidine should be routinely tested for intrathecal drug administration, especially in patients with a prominent neuropathic pain component.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Eisenach JC, De Kock M, Klimscha W: Alpha2-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984–1995). Anesthesiology 1996;85:655–674.
  2. Kulka PJ, Strumpf M, Tryba M, Zenz M: Alpha2-Adrenozeptor-Agonisten zur Therapie chronischer Schmerzen. Schmerz 1969;10:Heft 2.
  3. Estler CJ: Pharmakologie der alpha2-Adrenozeptoragonisten; in Tryba M, Zenz M (eds): Alpha2-Adrenozeptor-Agonisten in Anästhesie, Intensiv- und Schmerztherapie. Pabst, 1996, pp 32–53.
  4. Rockemann MG, Seeling W: Epidurale und intrathekale Anwendung von alpha2-Adrenozeptor-Agonisten zur postoperativen Analgesie. Schmerz 1996;10:Heft 2.
  5. Priddle HD, Andros GJ: Primary spinal anesthetic effects of epinephrine. Anesth Analg 1995;32:156–161.
  6. Motsch J: Epidurale/spinale Gabe von alpha2-Adrenozeptor-Agonisten und Opioid/Lokalanästhetika. Schmerz 1996;10:21–26.

    External Resources

  7. Coombs DW: Neurotoxicity of new intraspinal agents. Lancet 1984;ii:689–690.
  8. Tamsen A, Gordh T: Epidural clonidine produces analgesia. Lancet 1984;ii:231–232.
  9. Pern U, Tryba M, Zenz M, Tegenthoff H: Neue Möglichkeiten in der Therapie des Shivering; in Klose R, Büttner J (eds): Clonidin in Anästhesie und Intensivmedizin. Demeter, 1997, pp 53–60.
  10. Coombs DW, Saunders RL, Fratkin JD, Jensen LE, Murphy CA: Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. J Neurosurg 1986;64:890.

    External Resources

  11. Eisenach JC, Rauck RL, Buzzabell C, Lysak SZ: Epidural clonidine analgesia for intractable cancer pain: Phase I. Anesthesiology 1989;71:647.

    External Resources

  12. Täschner KL: Clonidin beim Opiatentzug; in Klose R, Büttner J (eds): Clonidin in Anästhesie und Intensivmedizin. Demeter, 1997, pp 33–36.
  13. Metz G, Nebel B, Corkin S, Bölch S, Kleinmann B: Intensivbehandlung des Alkoholentzugs mit Clonidin; in Klose R, Büttner J (eds): Clonidin in Anästhesie und Intensivmedizin. Demeter, 1997, pp 17–24.
  14. Sümpelmann R: Systemische Gabe von alpha2-Adrenozeptor-Agonisten zur post-operativen Analgesie. Schmerz 1995;9:192–198.
  15. De Kock M, Crochet B, Morimont C, Scholtes JL: Intravenous or epidural clonidine for intra- and post-operative analgesia. Anesthesiology 1993;79:525–531.
  16. Bonnet F, Boico O, Rostaining S, Loriferne JF, Saada M: Clonidine-induced analgesia in postoperative patients: Epidural versus intramuscular administration. Anesthesiology 1990;72:423–427.
  17. Filos KS, Goudas LC, Patroni O, Polyzou V: Hemodynamic and analgesic profile after intrathecal clonidine in humans. Anesthesiology 1992;81:591.
  18. Coombs DW, Jensen LE, Murphy C: Microdose intrathecal clonidine and morphine for postoperative analgesia. Anaesthesiology 1987;67:A238.
  19. Bonnet F: Alpha2-adrenergic agonists for regional anaesthesia; in Klose R, Büttner J (eds): Clonidin in Anästhesie und Intensivmedizin. Demeter, 1997, pp 41–43.
  20. Wilcox GL, Carlsson KH, Jochim A, Jurna I: Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory response in rat spinal cord. Brain Res 1987;405:84.
  21. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J: Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993;79:1163.
  22. Kabeer AA, Hardy PAJ: Long-term use of subarachnoid clonidine for analgesia in refractory reflex sympathetic dystrophy. Case report. Reg Anesth 1996;21:249–252.

    External Resources

  23. Coombs DW, Saunders RL, Lachance D, Savage S, Ragnarsson TS, Jensen LE: Intrathecal morphine tolerance: Use of intrathecal clonidine, DADLE, and intraventricular morphine. Anesthesiology 1985;62:358.

    External Resources

  24. Eisenach JC, Grice SC: Epidural clonidine does not decrease blood pressure or spinal cord blood flow in awake sheep. Anesthesiology 1988;68:335.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50